Screener
Corcept Therapeutics CORT Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 98.3%-0.1pp | 98.3%-0.2pp | 98.3%-0.1pp | 98.2%-0.2pp | 98.4%-0.1pp | |
| Operating margin | 0.8%-13.5pp | -1.1%-17.2pp | 5.9%-14.4pp | 8.8%-14.0pp | 14.2%-8.2pp | |
| Net margin | 6.6%-12.0pp | 6.2%-13.4pp | 13.1%-7.8pp | 14.3%-8.2pp | 18.7%-3.5pp | |
| Returns | ||||||
| Return on equity | 8.2%-13.5pp | 7.2%-14.6pp | 15%-8.8pp | 16.7%-9.1pp | 21.7%-3.1pp | |
| Return on invested capital | 1.1%-19.0pp | -1.4%-23.3pp | 8.2%-17.6pp | 12.8%-15.6pp | 20.1%-9.6pp | |
| Efficiency | ||||||
| Asset turnover | 1×0.0× | 0.9×0.0× | 0.9×0.0× | 0.9×0.0× | 0.9×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.9×-0.2× | 2.9×-0.2× | 2.9×-0.4× | 3.1×-0.6× | 3.1×-2.5× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -12.2×-11.3× | —— | -2.5×-1.6× | -1.8×-0.9× | -0.9×0.0× | |
| Per Share | ||||||
| Book value per share | $5.96+13.0% | $6.11+7.1% | $5.40-9.8% | $5.29-5.8% | $5.28-1.5% | |
| Valuation | ||||||
| Market capitalization | $11.67B+57.0% | $4.29B-64.4% | $3.66B-30.7% | $8.76B+81.1% | $8.14B+141% | |
| Price / earnings | 211.5×+156× | 90.6×+0.6× | 36.7×-0.7× | 82.5×+48.4× | 60.9×+34.1× | |
| Price / sales | 14.1×+3.7× | 5.6×-12.0× | 4.8×-3.0× | 11.8×+4.1× | 11.4×+5.4× | |
| Price / book | 16.5×+4.8× | 6.7×-10.9× | 5.7×-2.1× | 13.9×+6.3× | 12.8×+7.1× | |
| EV / EBITDA | 1,369.8×+1,299× | —— | 77.2×+39.7× | 129.5×+96.8× | 78×+52.6× |
FAQ
- What are Corcept Therapeutics's profit margins?
- Corcept Therapeutics (CORT) runs a 98.3% gross margin and a 0.8% operating margin, with a 6.6% net margin.
- Where do Corcept Therapeutics's ratios come from?
- Every ratio is computed from Corcept Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
